Angiodynamics Stock In The News

ANGO Stock  USD 9.01  0.11  1.21%   
Our overall analysis of AngioDynamics' news coverage and content from conventional and social sources shows investors' bearish mood towards AngioDynamics. The specific impact of AngioDynamics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of AngioDynamics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using AngioDynamics headlines in addition to utilizing other, more conventional financial analysis modules. Check out AngioDynamics Backtesting and AngioDynamics Hype Analysis.
To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.

AngioDynamics Today Top News and Investor Outlook

Yahoo News
AngioDynamics' (ANGO) New XL Catheter to Help in PAD Treatment
https://finance.yahoo.com/news/angiodynamics-ango-xl-catheter-help-153500743.html
 Bullish
Yahoo News
AngioDynamics Announces FDA 510(k) Clearance of Auryon XL Radial Access Catheter to Treat Peripheral Arterial Disease
https://finance.yahoo.com/news/angiodynamics-announces-fda-510-k-130000037.html
 Bullish
Yahoo News
AngioDynamics (ANGO) Q2 Earnings Top Estimates, Revenues Miss
https://finance.yahoo.com/news/angiodynamics-ango-q2-earnings-top-151700620.html
 Neutral
Yahoo News
AngioDynamics, Inc. (NASDAQ:ANGO) Q2 2024 Earnings Call Transcript
https://finance.yahoo.com/news/angiodynamics-inc-nasdaq-ango-q2-132958707.html
 Bullish
Yahoo News
Q2 2024 AngioDynamics Inc Earnings Call
https://finance.yahoo.com/news/q2-2024-angiodynamics-inc-earnings-052514166.html
 Bullish
Yahoo News
AngioDynamics Inc (ANGO) Reports Fiscal 2024 Second Quarter Results and Revises Full-Year Guidance
https://finance.yahoo.com/news/angiodynamics-inc-ango-reports-fiscal-191339313.html
 Bullish
Yahoo News
AngioDynamics (ANGO) Reports Q2 Loss, Misses Revenue Estimates
https://finance.yahoo.com/news/angiodynamics-ango-reports-q2-loss-131002108.html
 Bullish
Yahoo News
AngioDynamics Reports Fiscal Year 2024 Second Quarter Financial Results; Revises Fiscal Year 2024 Guidance
https://finance.yahoo.com/news/angiodynamics-reports-fiscal-2024-second-120000010.html
 Bullish
Yahoo News
Analysts Estimate AngioDynamics (ANGO) to Report a Decline in Earnings: What to Look Out for
https://finance.yahoo.com/news/analysts-estimate-angiodynamics-ango-report-150003052.html
 Bullish
Yahoo News
AngioDynamics to Present at the J.P. Morgan Healthcare Conference
https://finance.yahoo.com/news/angiodynamics-present-j-p-morgan-210100133.html
 Bullish

AngioDynamics Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide AngioDynamics and other traded companies coverage with news coverage. We help investors stay connected with AngioDynamics headlines for the 15th of March 2025 to make an informed investment decision based on correlating the impacts of news items on AngioDynamics Stock performance. Please note that trading solely based on the AngioDynamics hype is not for everyone as timely availability and quick action are needed to avoid losses.
AngioDynamics' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help AngioDynamics investors visualize upcoming and past events in order to time the market based on AngioDynamics noise-free hype analysis.
AngioDynamics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the AngioDynamics earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about AngioDynamics that are available to investors today. That information is available publicly through AngioDynamics media outlets and privately through word of mouth or via AngioDynamics internal channels. However, regardless of the origin, that massive amount of AngioDynamics data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of AngioDynamics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of AngioDynamics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to AngioDynamics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive AngioDynamics alpha.

AngioDynamics Largest EPS Surprises

Earnings surprises can significantly impact AngioDynamics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2014-04-09
2014-02-280.090.08-0.0111 
2014-01-09
2013-11-300.070.06-0.0114 
2013-10-10
2013-08-310.030.040.0133 
2013-07-11
2013-05-310.060.070.0116 
2013-01-03
2012-11-300.090.10.0111 
2012-10-08
2012-08-310.090.10.0111 
View All Earnings Estimates

AngioDynamics Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to AngioDynamics Stock. Current markets are strongly bullish. About 93% of major world exchanges and indexes are currently up. See today's market update for more information.
benzinga news
13th of March 2025
UiPath Posts Weak Revenue, Joins SentinelOne, American Eagle And Other Big Stocks Moving L...
at benzinga.com 
zacks News
6th of March 2025
The Cooper Companies Matches Q1 Earnings Estimates
at zacks.com 
Yahoo News
24th of February 2025
Several Insiders Invested In AngioDynamics Flagging Positive News
at finance.yahoo.com 
Yahoo News
12th of February 2025
Should You Add Penumbra Stock to Your Portfolio Right Now
at finance.yahoo.com 
zacks News
7th of February 2025
AngioDynamics Down 14.2 percent Since Last Earnings Report Can It Rebound
at zacks.com 
businesswire News
30th of January 2025
AngioDynamics Initiates AMBITION BTK RCT and Registry to Advance Treatment for Critical Li...
at businesswire.com 
Yahoo News
29th of January 2025
Cardiovascular Devices Market to Hit US110. Billion by 2029 with 7.3 percent CAGR Marketsa...
at finance.yahoo.com 
Yahoo News
21st of January 2025
Endorectal Balloon Market to Witness Remarkable Growth, Reaching US 549.7 Million by 2034 ...
at finance.yahoo.com 
Yahoo News
8th of January 2025
AngioDynamics Reports Fiscal Year 2025 Second Quarter Financial Results
at finance.yahoo.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards AngioDynamics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, AngioDynamics' short interest history, or implied volatility extrapolated from AngioDynamics options trading.
When determining whether AngioDynamics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AngioDynamics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Angiodynamics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Angiodynamics Stock:
Check out AngioDynamics Backtesting and AngioDynamics Hype Analysis.
To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.
You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AngioDynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.59)
Revenue Per Share
7.064
Quarterly Revenue Growth
(0.08)
Return On Assets
(0.06)
Return On Equity
(0.76)
The market value of AngioDynamics is measured differently than its book value, which is the value of AngioDynamics that is recorded on the company's balance sheet. Investors also form their own opinion of AngioDynamics' value that differs from its market value or its book value, called intrinsic value, which is AngioDynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AngioDynamics' market value can be influenced by many factors that don't directly affect AngioDynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AngioDynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AngioDynamics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioDynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.